In addition to the TfR-targeting ability, Tf was also found to act as a natural stabilizer in Tf-modified PTX NCs (PTX-Tf), which demonstrated good stability over at least 3 months at 4 °C, higher tumor inhibition rate than the unmodified counterpart, and lower toxicity than Taxol® [99]. The gene discussed is TF; the disease is neoplasm.